SANUWAVE Health Signs Strategic Agreement With Premier Shockwave to Manage OssaTron Devices

ALPHARETTA, Jul 22, 2014 (GLOBE NEWSWIRE via COMTEX) SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has signed a strategic agreement with Premier Shockwave, Inc. to manage the Company s OssaTron devices. The three year agreement with Premier Shockwave will provide SANUWAVE with an opportunity to monetize these assets, which represent the first and only extracorporeal shock wave therapy (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopedic conditions that have failed to respond to conservative treatment. Mike Stolarski, President and CEO of Premier Shockwave, Inc., stated, Having been in the shock wave industry for over 17 years, it is my experience and belief that the OssaTron truly is the gold standard for treating certain chronic orthopedic conditions, including plantar fasciitis and lateral epicondylitis. While the OssaTron is best known for the high profile professional athletes who have been treated wit
http://bit.ly/1r3BKsQ